The roles of soluble osteopontin using osteopontin-transgenic mice in vivo: Proliferation of CD4+ T lymphocytes and the enhancement of cell-mediated immune responses

Pathobiology

Volumn 71, Issue 1, 2004, Pages 1-11

  Higuchi, Yasunori ^a   Tamura, Yoichi ^a   Uchida, Tomohisa ^a   Matsuura, Keiko ^a   Hijiya, Naoki ^a   Yamamoto, Shunsuke ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Contact hypersensitivity; Hypersensitivity reaction; Osteopontin; T lymphocyte; Transgenic mice

Indexed keywords

1 FLUORO 2,4 DINITROBENZENE; ALPHA 1 ANTITRYPSIN; CD4 ANTIGEN; CD8 ANTIGEN; MESSENGER RNA; OSTEOPONTIN; PLASMA PROTEIN; TRINITROBENZENESULFONIC ACID; TURPENTINE OIL;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELLULAR IMMUNITY; CONTACT ALLERGY; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; EFFECTOR CELL; EMBRYO; FEMALE; HYPERSENSITIVITY REACTION; IN VIVO STUDY; KIDNEY; LIVER; LYMPH NODE; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PERITONEAL EXUDATE CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SENSITIZATION; SPLEEN; T LYMPHOCYTE; TISSUE DISTRIBUTION; TRANSGENIC MOUSE;

ADOPTIVE TRANSFER; ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; DERMATITIS, CONTACT; FEMALE; FLOW CYTOMETRY; IMMUNITY, CELLULAR; LYMPH NODES; MALE; MICE; MICE, TRANSGENIC; OSTEOPONTIN; SIALOGLYCOPROTEINS; SPLEEN;

MUS MUSCULUS;

EID: 0141924167     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000072956     Document Type: Article

References (34)

1. Craig AM, Smith JH, Denhardt DT: Osteopon-tin, a transformation-associated cell adhesion phosphoprotein, is induced by 12-O-tetradecanoylphorbol 13-acetate in mouse epidermis. J Biol Chem 1989;264:9682-9689.
2. Miyazaki Y, Setoguchi M, Yoshida S, Higuchi Y, Akizuki S, Yamamoto S: The mouse osteo-pontin gene. Expression in monocytic lineages and complete nucleotide sequence. J Biol Chem 1990;265:14432-14438.
3. Oldberg A, Franzen A, Heinegard D: Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proc Natl Acad Sci USA 1986;83:8819-8823.
4. Denhardt DT, Guo X: Osteopontin: A protein with diverse functions. FASEB J 1993;7:1475-1482.
5. Hijiya N, Setoguchi M, Matsuura K, Higuchi Y, Akizuki S, Yamamoto S: Cloning and characterization of the human osteopontin gene and its promoter. Biochem J 1994;303/1:255-262.
6. Yamamoto S, Hijiya N, Setoguchi M, Matsuura K, Ishida T, Higuchi Y, Akizuki S: Structure of the osteopontin gene and its promoter. Ann NY Acad Sci 1995;760:44-58.
7. O'Regan AW, Chupp GL, Lowry JA, Goetschkes M, Mulligan N, Berman JS: Osteopontin is associated with T cells in sarcoid granulomas and has T cell adhesive and cytokine-like properties in vitro. J Immunol 1999; 162:1024-1031.
8. O'Regan AW, Nau GJ, Chupp GL, Berman JS: Osteopontin (Eta-1) in cell-mediated immunity: Teaching an old dog new tricks. Immunol Today 2000;21:475-478.
9. Nau GJ, Guilfoile P, Chupp GL, Berman JS, Kim SJ, Kornfeld H, Young RA: A chemoattractant cytokine associated with granulomas in tuberculosis and silicosis. Proc Natl Acad Sci USA 1997;94:6414-6419.
10. Patarca R, Freeman GJ, Singh RP, Wei FY, Durfee T, Blattner F, Regnier DC, Kozak CA, Mock BA, Morse HC 3rd, et al: Structural and functional studies of the early T lymphocyte activation 1 (Eta-1) gene. Definition of a novel T cell-dependent response associated with genetic resistance to bacterial infection. J Exp Med 1989;170:145-161.
11. Lampe MA, Patarca R, Iregui MV, Cantor H: Polyclonal B cell activation by the Eta-1 cytokine and the development of systemic autoimmune disease. J Immunol 1991;147:2902-2906.
12. Nasu K, Ishida T, Setoguchi M, Higuchi Y, Akizuki S, Yamamoto S: Expression of wild-type and mutated rabbit osteopontin in Escherichia coli, and their effects on adhesion and migration of P388D1 cells. Biochem J 1995; 307/1:257-265.
13. Nau GJ, Liaw L, Chupp GL, Berman JS, Hogan BL, Young RA: Attenuated host resistance against Mycobacterium bovis BCG infection in mice lacking osteopontin. Infect Immun 1999; 67:4223-4230.
14. Giachelli CM, Lombardi D, Johnson RJ, Murry CE, Almeida M: Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am J Pathol 1998;152:353-358.
15. Ashkar S, Weber GF, Panoutsakopoulou V, Sanchirico ME, Jansson M, Zawaideh S, Rittling SR, Denhardt DT, Glimcher MJ, Cantor H: Eta-1 (osteopontin): An early component of type-1 (cell-mediated) immunity. Science 2000;287:860-864.
16. Iizuka J, Katagiri Y, Tada N, Murakami M, Ikeda T, Sato M, Hirokawa K, Okada S, Hatano M, Tokuhisa T, Uede T: Introduction of an osteopontin gene confers the increase in B1 cell population and the production of anti-DNA autoantibodies. Lab Invest 1998;78:1523-1533.
17. Weiss JM, Renkl AC, Maier CS, Kimmig M, Liaw L, Ahrens T, Kon S, Maeda M, Hotta H, Uede T, Simon JC: Osteopontin is involved in the initiation of cutaneous contact hypersensitivity by inducing Langerhans and dendritic cell migration to lymph nodes. J Exp Med 2001;194:1219-1229.
18. Biancone L, Araki M, Araki K, Vassalli P, Stamenkovic I: Redirection of tumor metastasis by expression of E-selectin in vivo. J Exp Med 1996;183:581-587.
19. Tamura Y, Higuchi Y, Kataoka M, Akizuki S, Matsuura K, Yamamoto S: CD14 transgenic mice expressing membrane and soluble forms: Comparisons of levels of cytokines and lethalities in response to lipopolysaccharide between transgenic and non-transgenic mice. Int Immunol 1999;11:333-339.
20. Setoguchi M, Higuchi Y, Yoshida S, Nasu N, Miyazaki Y, Akizuki S, Yamamoto S: Insertional activation of N-myc by endogenous Moloney-like murine retrovirus sequences in macrophage cell lines derived from myeloma cell line-macrophage hybrids. Mol Cell Biol 1989; 9:4515-4522.
21. Desvignes C, Etchart N, Kehren J, Akiba I, Nicolas JF, Kaiserlian D: Oral administration of hapten inhibits in vivo induction of specific cytotoxic CD8+ T cells mediating tissue inflammation: A role for regulatory CD4+ T cells. J Immunol 2000;164:2515-2522.
22. Higuchi Y, Yasui A, Matsuura K, Yamamoto S: CD156 transgenic mice. Different responses between inflammatory types. Pathobiology 2002;70:47-54.
23. Sodek J, Chen J, Nagata T, Kasugai S, Todescan R Jr, Li IW, Kim RH: Regulation of osteopontin expression in osteoblasts. Ann NY Acad Sci 1995;760:223-241.
24. O'Regan AW, Hayden JM, Body S, Liaw L, Mulligan N, Goetschkes M, Berman JS: Abnormal pulmonary granuloma formation in osteopontin-deficient mice. Am J Respir Crit Care Med 2001;164:2243-2247.
25. Carlson I, Tognazzi K, Manseau EJ, Dvorak HF, Brown LF: Osteopontin is strongly expressed by histiocytes in granulomas of diverse etiology. Lab Invest 1997;77:103-108.
26. Liaw L, Skinner MP, Raines EW, Ross R, Cheresh DA, Schwartz SM, Giachelli CM: The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro. J Clin Invest 1995;95:713-724.
27. Weber GF, Ashkar S, Glimcher MJ, Cantor H: Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 1996;271: 509-512.
28. Senger DR, Ledbetter SR, Claffey KP, Papadopoulos-Sergiou A, Peruzzi CA, Detmar M: Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin. Am J Pathol 1996; 149:293-305.
29. Anderson C, Hehr A, Robbins R, Hasan R, Athar M, Mukhtar H, Elmets CA: Metabolic requirements for induction of contact hypersensitivity to immunotoxic polyaromatic hydrocarbons. J Immunol 1995;155:3530-3537.
30. Gautam SC, Matriano JA, Chikkala NF, Edinger MG, Tubbs RR: L3T4 (CD4+) cells that mediate contact sensitivity to trinitrochloro-benzene express I-A determinants. Cell Immunol 1991;135:27-41.
31. Kondo S, Beissert S, Wang B, Fujisawa H, Kooshesh F, Stratigos A, Granstein RD, Mak TW, Sauder DN: Hyporesponsiveness in contact hypersensitivity and irritant contact dermatitis in CD4 gene targeted mouse. J Invest Dermatol 1996;106:993-1000.
32. Bour H, Peyron E, Gaucherand M, Garrigue JL, Desvignes C, Kaiserlian D, Revillard JP, Nicolas JF: Major histocompatibility complex class I-restricted CD8+ T cells and class II-restricted CD4+ T cells, respectively, mediate and regulate contact sensitivity to dinitrofluorobenzene. Eur J Immunol 1995;25:3006-3010.
33. Gocinski BL, Tigelaar RE: Roles of CD4+ and CD8+ T cells in murine contact sensitivity revealed by in vivo monoclonal antibody depletion. J Immunol 1990;144:4121-4128.
34. Wang B, Fujisawa H, Zhuang L, Freed I, Howell BG, Shahid S, Shivji GM, Mak TW, Sauder DN: CD4+ Th1 and CD8+ type 1 cytotoxic T cells both play a crucial role in the full development of contact hypersensitivity. J Immunol 2000;165:6783-6790.